Andy Barnett
Head of Investor Relations
Replay available
AstraZeneca PLC (AZN) Q3 2025 Earnings Call
AstraZeneca PLC (NASDAQ: AZN) Q3 2025 earnings conference call, held 2025-11-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Pascal Soriot
Chief Executive Officer
Dave Fredrickson
Executive Vice President, Oncology Business Unit
Susan Galbraith
Executive Vice President, Oncology R&D
Ruud Dobber
Executive Vice President, Biopharmaceuticals Business Unit
Mark Mallon
Executive Vice President, Rare Disease Business Unit
Michael Lushton
Analyst, Jefferies
Sarita Kapila
Analyst, Morgan Stanley
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Astrazeneca Plc.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.357 Good afternoon and welcome to AstraZeneca's nine-month and Q3 2025 webinar 00:00:05.357 -- 00:00:08.121 for investors and analysts. 00:00:08.121 -- 00:00:13.385 Before I hand over to AstraZeneca, I'd like to read the Safe Harbor Statement. 00:00:13.707 -- 00:00:17.812 The company intends to utilize the Safe Harbor provisions of the United States Private 00:00:17.812 -- 00:00:22.055 Securities Litigation Reform Act of 1995. 00:00:22.197 -- 00:00:26.683 Participants on this call may make forward-looking statements with respect to the operations 00:00:26.683 -- 00:00:29.866 and financial performance of AstraZeneca. 00:00:29.866 -- 00:00:34.270 Although we believe our expectations are based on reasonable assumptions, by their very 00:00:34.270 -- 00:00:39.376 nature, forward-looking statements involve risks and uncertainties and may be influenced 00:00:39.376 -- 00:00:44.321 by factors that could cause actual results to differ materially from those expressed 00:00:44.321 -- 00:00:47.944 or implied by these forward-looking statements. 00:00:47.944 -- 00:00:51.748 Any forward-looking statements made on this call reflect the knowledge and information 00:00:51.748 -- 00:00:55.071 available at the time of this call. 00:00:55.071 -- 00:00:59.994 The company undertakes no obligation to update forward-looking statements. 00:01:00.089 -- 00:01:03.933 Please carefully review the forward-looking statements disclaimer in the slide deck that 00:01:03.933 -- 00:01:07.077 accompanies this presentation and webcast. 00:01:07.077 -- 00:01:11.002 There will be an opportunity to ask questions after today's presentation. 00:01:11.002 -- 00:01:15.407 Please use the raise a hand feature to indicate you wish to ask a question at any time 00:01:15.407 -- 00:01...